All Companies
Ticker ALMS
Foundation Sweep — share basis uncertain
You reached the page — here's exactly what ALMS is, and why it's out of scope for now.
What this ticker is
ALMS
Alumis Inc.
NASDAQ
Healthcare
Biotechnology
United States
Mkt cap $1.3B
Alumis Inc. is a clinical-stage biopharmaceutical company focused on developing targeted therapies for immune-mediated diseases. The company’s current pipeline centers on oral TYK2 inhibitors designed to address conditions such as plaque psoriasis and systemic lupus erythematosus, alongside a CNS-penetrant TYK2 program being studied for neuroinflammatory an…
Why we can't analyze it yet
F5 · Only the share HISTORY dissents (unadjusted split/issuance in old rows) · divisor 85,029,624 — 1 witness(es) agree [eps_identity]; CONFLICT with [continuity]
Delvantic analyzes regular securities of single operating companies — one business with revenue, earnings and cash flows our valuation methods can assess bottom-up.
Reason code:
share_basis_unverified